Vasotocin
|
Names |
IUPAC name
1-[(1R,4S,7S,13S,16R)-16-amino-4-(2-amino-2-oxoethyl)-7-(3-amino-3-oxopropyl)-10-[(2S)-butan-2-yl]-13-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-18,19-dithia-2,5,8,11,14-pentazacycloicosane-1-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pyrrolidine-2-carboxamide
|
Other names
Argiprestocin; Arg-vasotocin; 8-Arg-vasotocin; Arginine vasotocin
|
Identifiers |
CAS Registry Number
|
113-80-4 Y |
ChEBI |
CHEBI:78364 N |
Jmol-3D images |
Image |
PubChem |
68649 |
SMILES
-
CC[C@H](C)C1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
|
Properties |
Molecular formula
|
C43H67N15O12S2 |
Molar mass |
1,050.22 g·mol−1 |
Except where noted otherwise, data is given for materials in their standard state (at 25 °C (77 °F), 100 kPa)
|
N verify (what is: Y/N?) |
Infobox references |
|
|
Vasotocin is an oligopeptide homologous to oxytocin and vasopressin found in all non-mammalian vertebrates (including birds, fishes, and amphibians) and possibly in mammals during the fetal stage of development. Arginine vasotocin (AVT), a hormone produced by neurosecretory cells within the posterior pituitary gland (neurohypophysis) of the brain, is a major endocrine regulator of water balance and osmotic homoeostasis and is involved in social and sexual behavior in non-mammalian vertebrates. In mammals, it appears to have biological properties similar to those of oxytocin (stimulating reproductive tract contraction as in egg laying or birth) and vasopressin (diuretic and antidiuretic effects). It has been found to have effects on the regulation of REM sleep.[1] Evidence for the existence of endogenous vasotocin in mammals is limited[2][3] and no mammalian gene encoding vasotocin has been confirmed.
AVT (Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH2), which occurs in the lamprey, represents the ancestral form in the phylogeny of the vertebrate neurohypophysial hormones.[4] Gene duplication and point mutation have produced two distinct lineages, one involved in reproduction (oxytocin-like peptides) and the other in osmoregulation (vasopressin-like peptides). These hormones have remained highly conserved throughout evolution. Each is a peptide of nine amino acids derived from a preprohormone precursor by proteolytic cleavage, with an intramolecular disulfide bridge between the cysteine (Cys) residues; the C-terminal glycine (Gly) residue is amidated. Six of the residues have been found to be invariant in homologous peptides from numerous species of vertebrates. The vasopressin-like peptides, which differ in positions 3 and/or 8, include AVT and the mammalian hormones arginine vasopressin (Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2, with isoleucine-3 of AVT changed to phenylalanine) and lysine vasopressin (isoleucine-3 changed to phenylalanine and arginine-8 changed to lysine). The oxytocin-like peptides, which differ in positions 4 and/or 8, include oxytocin (Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, with arginine-8 of AVT changed to leucine), mesotocin (arginine-8 changed to isoleucine), and isotocin (glutamine-4 changed to serine and arginine-8 changed to isoleucine); they differ from the vasopressin-like peptides in having a neutral amino acid in place of a basic amino acid at position 8. Oxytocin occurs in placental mammals; mesotocin occurs in amphibians, reptiles, and birds, and isotocin occurs in fishes.
Contents
- 1 Biosynthesis
- 2 Behavioral Effects
- 3 Sources
- 4 External links
Biosynthesis
AVT is synthesized as a preprohormone that includes a second peptide, neurophysin VT (neurophysins are carrier proteins that are secreted along with their passenger hormones); intracellular proteolytic processing generates the mature peptides. In the chicken (Gallus gallus), the 161-amino acid vasotocin-neurophysin VT preprohormone is encoded by the gene AVP, which is considered homologous to the mammalian genes encoding arginine vasopressin.[5] Removal of the 19-amino acid N-terminal signal peptide generates the prohormone, which is hydrolysed to AVT (derived from amino acids 20-28) and neurophysin VT (derived from amino acids 32-161).[6] The existence of two AVT preprohormones with different sequences in fishes (such as chum salmon, Oncorhynchus keta[7]) is evidence for gene duplication.
Behavioral Effects
Several animal studies have been conducted that explore the behavioral effects of AVT. The main findings of these studies have revealed that AVT plays an integral role in the pair bonding behavior and social hierarchy in non-mammalian vertebrates.
In a study conducted with zebra finches,[8] increased levels of AVT were linked to an increase in aggressive, competitive behavior in non-paired male finches, but were subsequently related to an increase in defensive behavior after the finches had been paired. However, this study also found that blocking AVT receptors did not directly affect pair bonding ability. The shift in behaviors were explained by the location of the release of AVT in the brain. Competitive aggressive behavior was found to be linked with AVT release in the BSTm, whereas defensive, nest-protecting behavior was linked with AVT release in the neurons of the Hypothalamus and Paraventricular Nucleus.
In a study conducted with male Japanese quail, AVT was found to have an effect on later social interactions amongst the species. Immediately after injection with AVT, the quails displayed less aggressive behavior (pecking). However, the next day, the quail that were injected with AVT displayed more dominant behavior towards familiar birds, but not unfamiliar birds. This study shows that AVT may play a role in establishing social hierarchy.[9]
A study that investigated the role of social construction and AVT compared territorial and non-territorial species of tropical coral reef fish.[10] Experimenters administered Manning compound, an AVT agonist to the fish and found that, after treatment, non-territorial species displayed more territorial behavior whereas territorial species displayed less territorial behavior.
Research suggests that the effects of AVT on aggression may be influenced by the social construction of the species. For example, in a study done with Rainbow Trout,[11] increased levels of AVT were associated with more subordinate behavior. It is currently hypothesized that the contrasting effects of AVT are related to the distinction between territorial versus colonial social systems. In a territorial species, such as Rainbow Trout, AVT is linked to less dominant behavior. This may be due to the differences in the distribution of AVT receptors in territorial and colonial species.
Sources
- ^ Kales, Anthony (1995). The Pharmacology of sleep. Berlin: Springer-Verlag. ISBN 3-540-58961-9.
- ^ Ervin MG, Leake RD, Ross MG, Calvario GC, Fisher DA (May 1985). "Arginine vasotocin in ovine fetal blood, urine, and amniotic fluid". J Clin Invest. 75 (5): 1696–701. doi:10.1172/JCI111878. PMID 3998151.
- ^ Ervin MG, Amico JA, Leake RD, Ross MG, Robinson AG, Fisher DA (1988). "Arginine vasotocin and a novel oxytocin-vasotocin-like material in plasma of human newborns". Biol Neonate 53 (1): 17–22. doi:10.1159/000242757. PMID 3355867.
- ^ Liu JW, Ben-Jonathan N (January 1994). "Prolactin-releasing activity of neurohypophysial hormones: structure-function relationship". Endocrinology 134 (1): 114–18. doi:10.1210/en.134.1.114. PMID 8275925.
- ^ "AVP arginine vasopressin (neurophysin II, antidiuretic hormone, diabetes insipidus, neurohypophyseal) [ Gallus gallus (chicken) ], Entrez Gene ID 396101".
- ^ "Vasotocin-neurophysin VT, UniProtKB/Swiss-Prot P24787 (NEUV_CHICK)".
- ^ Heierhorst J, Mahlmann S, Morley SD, Coe IR, Sherwood NM, Richter D (January 1990). "Molecular cloning of two distinct vasotocin precursor cDNAs from chum salmon (Oncorhynchus keta) suggests an ancient gene duplication". FEBS Lett. 260 (2): 301–4. doi:10.1016/0014-5793(90)80129-7. PMID 2298304.
- ^ Kabelik D, Klatt JD, Kingsbury MA, Goodson JL. Endogenous vasotocin exerts contexts-dependent behavioral effects in semi-naturalistic colony environment. Hormones and Behavior. 2009;56(1): 101-107.
- ^ Riters LV, and Panksepp J. Effects of vasotocin on aggressive behavior in male Japanese quail. Annals of the New York Academy of Sciences. 2006; 807(1): 478-480.
- ^ Semsar K, Kandel FLM, Godwin J. Manipulations of the AVT system shift social status and related courtship behavior in the Bluehead Wrasse. Hormones and Behavior. 2001; 40(1): 21-31.
- ^ Backström T, and Winberg S. Arginine vasotocin influence on aggressive behavior and dominance in rainbow trout. Physiology and Behavior. 2009; 96(3): 470-475.
External links
- Vasotocin at the US National Library of Medicine Medical Subject Headings (MeSH)
Neuropeptidergics
|
|
CGRP |
- Agonists: Amylin
- CGRP
- Pramlintide
- Antagonists: BI 44370 TA
- BMS-927711
- CGRP (8-37)
- MK-3207
- Olcegepant
- SB-268262
- Telcagepant
- Ubrogepant
|
|
Cholecystokinin |
CCKA
|
- Agonists: Cholecystokinin
- CCK-4
Antagonists: Amiglumide
- Asperlicin
- Devazepide
- Dexloxiglumide
- Lintitript
- Lorglumide
- Loxiglumide
- Pranazepide
- Proglumide
- Tarazepide
- Tomoglumide
|
|
CCKB
|
- Agonists: Cholecystokinin
- CCK-4
- Gastrin
Antagonists: CI-988 (PD-134,308)
- Itriglumide
- L-365,360
- Netazepide
- Proglumide
- Spiroglumide
|
|
|
CRH |
CRF1
|
- Agonists: Cortagine
- Corticorelin
- Corticotropin releasing hormone
- Sauvagine
- Stressin I
- Urocortin
Antagonists: Antalarmin
- Astressin-B
- CP-154,526
- Emicerfont
- Hypericin
- LWH-234
- NBI-27914
- Pexacerfont
- R-121,919
- TS-041
- Verucerfont
|
|
CRF2
|
- Agonists: Corticorelin
- Corticotropin releasing hormone
- Sauvagine
- Urocortin
Antagonists: Astressin-B
|
|
|
Galanin |
GAL1
|
- Agonists: Galanin
- Galanin (1-15)
- Galanin-like peptide
- Galmic
- Galnon
Antagonists: C7
- Dithiepine-1,1,4,4-tetroxide
- Galantide (M15)
- M32
- M35
- M40
- SCH-202596
|
|
GAL2
|
- Agonists: Galanin
- Galanin (1-15)
- Galanin (2-11)
- Galanin-like peptide
- Galmic
- Galnon
- J18
Antagonists: C7
- Galantide (M15)
- M32
- M35
- M40
- M871
|
|
GAL3
|
- Agonists: Galanin
- Galanin (1-15)
- Galmic
- Galnon
Antagonists: C7
- Galantide (M15)
- GalR3ant
- HT-2157
- M32
- M35
- M40
- SNAP-37889
- SNAP-398299
|
|
|
MCH |
MCH1
|
- Agonists: Melanin concentrating hormone
Antagonists: ATC-0175
- GW-803,430
- NGD-4715
- SNAP-7941
- SNAP-94847
|
|
MCH2
|
- Agonists: Melanin concentrating hormone
|
|
|
Melanocortin |
MC1
|
- Agonists: α-MSH
- β-MSH
- γ-MSH
- ACTH (corticotropin)
- Afamelanotide
- BMS-470,539
- Bremelanotide
- Melanotan II
- PL-8177
- SHU-8914
- SHU-9005
- SHU-9119
Antagonists: ASIP
|
|
MC2
|
- Agonists: ACTH (corticotropin)
- Alsactide
- Codactide
- Cosyntropin (cortrosyn)
- Giractide
- Norleusactide (pentacosactride)
- Seractide
- Tetracosactide (tetracosactrin)
- Tosactide (octacosactrin)
- Tricosactide
- Tridecactide
|
|
MC3
|
- Agonists: α-MSH
- β-MSH
- γ-MSH
- ACTH (corticotropin)
- Bremelanotide
- Melanotan II
- PG-931
Antagonists: AGRP
- ASIP
- ML-00253764
- PG-106
- SHU-8914
- SHU-9005
- SHU-9119
|
|
MC4
|
- Agonists: α-MSH
- β-MSH
- γ-MSH
- ACTH (corticotropin)
- AZD2820
- Bremelanotide
- Melanotan II
- MK-0493
- PF-00446687
- PG-931
- PL-6983
- RM-493 (BIM-22493)
- Ro 27-3225
- THIQ
Antagonists: AGRP
- ASIP
- HS-014
- HS-024
- JKC-363
- MCL-0020
- MCL-0042
- MCL-0129
- ML-00253764
- MPB-10
- SHU-8914
- SHU-9005
- SHU-9119
Unknown: Semax
|
|
MC5
|
- Agonists: α-MSH
- β-MSH
- γ-MSH
- ACTH (corticotropin)
- Melanotan II
- SHU-8914
- SHU-9005
- SHU-9119
Antagonists: ASIP
- ML-00253764
Unknown: Semax
|
|
Unsorted
|
- Agonists: Alsactide
- Codactide
- Cosyntropin (cortrosyn)
- Giractide
- Norleusactide (pentacosactride)
- Seractide
- Tetracosactide (tetracosactrin)
- Tosactide (octacosactrin)
- Tricosactide
- Tridecactide
|
|
|
Neuropeptide S |
- Agonists: Neuropeptide S
Antagonists: SHA-68
|
|
Neuropeptide Y |
Y1
|
- Agonists: Neuropeptide Y
- Peptide YY
Antagonists: BIBP-3226
|
|
Y2
|
- Agonists: Neuropeptide Y
- Peptide YY
Antagonists: BIIE-0246
|
|
Y4
|
- Agonists: Neuropeptide Y
- Pancreatic polypeptide
- Peptide YY
Antagonists: UR-AK49
|
|
Y5
|
- Agonists: Neuropeptide Y
- Peptide YY
Antagonists: Lu AA-33810
|
|
|
Neurotensin |
NTS1
|
- Agonists: Neurotensin
- Neuromedin N
Antagonists: Meclinertant
- SR-142,948
|
|
NTS2
|
- Agonists: Neurotensin
Antagonists: Levocabastine
- SR-142,948
|
|
|
Opioid |
See here instead.
|
|
Orexin |
OX1
|
- Agonists: Orexin-A
- Orexin-B
Antagonists: ACT-335827
- Almorexant
- Filorexant
- SB-334,867
- SB-408,124
- SB-649,868
- Suvorexant
|
|
OX2
|
- Agonists: Orexin-A
- Orexin-B
- SB-668,875
Antagonists: ACT-335827
- Almorexant
- EMPA
- Filorexant
- JNJ-10397049
- MK-1064
- SB-649,868
- Suvorexant
- TCS-OX2-29
|
|
|
Oxytocin |
- Agonists: Aspartocin
- Carbetocin
- Cargutocin
- Demoxytocin
- Nacartocin
- Oxytocin
- TC OT 39
- TGOT
- Vasotocin (argiprestocin)
- WAY-267,464
Antagonists: Atosiban
- Barusiban
- Epelsiban
- L-368,899
- L-371,257
- L-372,662
- OBE001
- Retosiban
- SSR-126,768
- Tocinoic acid
- WAY-162,720
|
|
Tachykinin |
NK1
|
- Agonists: Substance P
Antagonists: Aprepitant
- Befetupitant
- Burapitant
- Casopitant
- CI-1021
- CP-96,345
- CP-99,994
- CP-122,721
- Dapitant
- Ezlopitant
- Figopitant
- FK-888
- Fosaprepitant
- GR-203,040
- GW-597,599
- HSP-117
- L-733,060
- L-741,671
- L-743,310
- L-758,298
- Lanepitant
- LY-306,740
- Maropitant
- Netupitant
- NKP-608
- Nolpitantium besilate
- Orvepitant
- Rolapitant
- RP-67,580
- SDZ NKT 343
- Serlopitant
- Telmapitant
- Vestipitant
- Vofopitant
|
|
NK2
|
- Agonists: Neurokinin A
Antagonists: GR-159,897
- Ibodutant
- Nepadutant
- Saredutant
|
|
NK3
|
- Agonists: Neurokinin B
Antagonists: Osanetant
- Talnetant
|
|
|
Vasopressin |
V1A
|
- Agonists: Felypressin
- Lypressin
- Ornipressin
- Selepressin
- Terlipressin
- Vasopressin (argipressin)
- Vasotocin (argiprestocin)
Antagonists: Atosiban
- Conivaptan
- Demeclocycline
- PF-184563
- Relcovaptan
- RG7314
- SRX246
- TC OT 39
- WAY-267,464
|
|
V1B
|
- Agonists: Desmopressin
- Felypressin
- Lypressin
- Ornipressin
- Terlipressin
- Vasopressin (argipressin)
- Vasotocin (argiprestocin)
Antagonists: ABT-436
- Demeclocycline
- Nelivaptan
|
|
V2
|
- Agonists: Desmopressin
- Felypressin
- Lypressin
- Ornipressin
- TC OT 39
- Terlipressin
- Vasopressin (argipressin)
- Vasotocin (argiprestocin)
Antagonists: Conivaptan
- Demeclocycline
- Lixivaptan
- Mozavaptan
- Satavaptan
- Tolvaptan
|
|
|
See also: Peptidergics
|
|